The Adrenal Glands and Glucose Metabolism

The adrenal glands, small triangular organs perched atop each kidney, serve as a critical hub for hormone production that directly influences glucose metabolism. The two main hormones of interest in diabetes care are cortisol and adrenaline (epinephrine). Cortisol is often called the stress hormone, but its role extends far beyond that; it helps regulate blood sugar by promoting gluconeogenesis (production of glucose from non-carbohydrate sources) in the liver and reducing peripheral insulin sensitivity. Adrenaline, released during acute stress or physical activity, triggers the liver to release stored glucose into the bloodstream, providing a rapid energy source.

These hormones operate on a daily rhythm — cortisol peaks in the morning to help wake you up and declines throughout the day. In people with healthy adrenal function, this rhythm is tightly controlled. However, chronic stress, illness, or adrenal disorders can disrupt this cycle, leading to persistently elevated or depleted cortisol levels. This disruption can wreak havoc on blood sugar control, making it harder for people with diabetes to maintain stable glucose readings. Understanding this relationship is the first step toward appreciating why adrenal gland testing can be a game-changer in fine-tuning diabetes treatment plans.

Why Adrenal Dysfunction Matters in Diabetes

Diabetes management typically focuses on insulin dosing, carbohydrate counting, and oral medications. Yet even the most meticulous plan can fail when adrenal hormones are out of balance. Two common scenarios illustrate the impact.

Cortisol Excess (Cushing’s Syndrome)

In conditions where cortisol is chronically elevated — either from a tumor, long-term steroid use, or chronic stress — the body becomes resistant to insulin. The liver churns out glucose even when blood sugar is already high. Patients often have elevated fasting glucose, postprandial hyperglycemia, and require escalating doses of insulin or oral agents. Without addressing the underlying cortisol excess, diabetes medications become less effective.

Cortisol Deficiency (Adrenal Insufficiency)

Conversely, when the adrenal glands produce too little cortisol (primary adrenal insufficiency, or Addison’s disease, or secondary insufficiency from pituitary issues), blood sugar can drop dangerously low, particularly overnight or between meals. Patients with diabetes who also have adrenal insufficiency may experience frequent, unexplained hypoglycemic episodes. This is especially dangerous for those on insulin or sulfonylureas. Treating the adrenal deficiency — often with low-dose hydrocortisone — can stabilize blood sugar and reduce hypoglycemia risk.

Additionally, adrenaline imbalances can contribute to the dawn phenomenon (early morning hyperglycemia) or cause stress-induced spikes. By identifying these adrenal drivers, clinicians can move beyond generic treatment protocols and create a plan that addresses the root cause.

Who Should Consider Adrenal Gland Testing in Diabetes?

Not every person with diabetes needs adrenal testing. However, certain clinical clues should prompt a discussion with an endocrinologist:

  • Unstable blood sugar despite adherence — especially if you have wide swings from high to low without clear explanation.
  • Unexplained hypoglycemia — particularly in the morning or after missed meals, which may signal cortisol deficiency.
  • Resistant hypertension — combined with diabetes, excess cortisol or aldosterone can be a factor.
  • Fatigue, weight changes, or muscle weakness — classic signs of adrenal dysfunction.
  • Post-operative or critical illness — temporary adrenal suppression can occur after steroids or severe stress.
  • Use of inhaled or topical steroids — high doses can suppress the adrenal axis.

If you recognize any of these patterns in your own diabetes journey, adrenal testing may uncover a missing piece of the puzzle.

How Adrenal Testing Works

Adrenal gland testing is not a single test but rather a panel of assessments designed to measure hormone levels at different times and under different conditions. The choice of test depends on the suspected imbalance.

Blood Tests

Serum cortisol is often measured in the morning (8 a.m.) when it should be at its peak. A low morning cortisol can indicate adrenal insufficiency. An ACTH stimulation test (cosyntropin test) is the gold standard for diagnosing adrenal insufficiency. A synthetic form of ACTH is injected, and cortisol levels are measured at 30 and 60 minutes. A blunted response confirms impaired adrenal reserve.

Salivary Tests

Late-night salivary cortisol is used to screen for Cushing’s syndrome. Cortisol should be very low at midnight; elevated levels suggest overproduction. Salivary testing is convenient, non-invasive, and can be done at home, making it a popular first step in screening.

Urine Tests

24-hour urinary free cortisol measures total cortisol excretion over a full day. This avoids the timing issues of single blood or saliva samples and provides an integrated view of daily production. It is useful for confirming or ruling out Cushing’s syndrome.

Other Relevant Hormones

Adosterone and renin testing may be warranted if blood pressure is difficult to control or if electrolyte abnormalities (such as low potassium) are present. DHEA-S (dehydroepiandrosterone sulfate) is another adrenal androgen that can be low in adrenal fatigue or insufficiency.

It is crucial to interpret these tests in the context of the patient's age, time of day, recent illness, and medications (including oral contraceptives or hormone therapy). For accurate results, patients may need to stop certain medications or avoid strenuous exercise before testing.

Interpreting Adrenal Test Results in Diabetes

Understanding what your results mean is the key to using them in treatment. Here are common patterns:

  • Low morning cortisol + poor ACTH response → primary or secondary adrenal insufficiency. Often requires hydrocortisone replacement, which can then lower insulin requirements.
  • High late-night salivary cortisol or elevated 24-hour urinary cortisol → Cushing’s syndrome. May need further imaging (pituitary MRI, adrenal CT) and treatment — surgical or medical — to lower cortisol, often leading to improved diabetes control.
  • Borderline results → may indicate “subclinical” dysfunction or the effect of chronic stress. In such cases, lifestyle intervention and stress reduction may be sufficient.

These interpretations are nuanced and require an experienced endocrinologist, especially because many factors (like estrogen therapy) can affect cortisol binding globulin and skew results.

Applying Results to Diabetes Treatment Plans

Once adrenal dysfunction is identified, the diabetes treatment plan can be adjusted in several targeted ways.

Adjusting Insulin and Oral Medications

For those with cortisol deficiency, starting low-dose hydrocortisone (usually 10–20 mg daily in divided doses) can stabilize morning glucose and reduce hypoglycemia. Insulin doses — especially basal insulin — may need to be decreased. Conversely, patients with cortisol excess often require higher insulin doses, and if the cortisol source is removed (e.g., surgical removal of an adrenal adenoma), insulin needs can plummet dramatically. Close monitoring is required during these transitions to avoid both hyper- and hypoglycemia.

Lifestyle and Stress Management

Even without a formal adrenal disorder, chronic stress elevates cortisol, impairing glucose control. Behavioral interventions — mindfulness, sleep hygiene, regular exercise (not overtraining), and structured breaks — can help lower cortisol naturally. For patients with burnout or fatigue, a “stress prescription” that includes adequate recovery time may improve both adrenal health and diabetes outcomes.

Hormone Therapy and Supplements

In cases of documented adrenal insufficiency, bioidentical hydrocortisone or prednisolone are standard. DHEA supplementation can improve energy and mood in women with low DHEA-S. However, self-prescription of adrenal supplements (like “adrenal glandulars” or adaptogenic herbs) without proper testing is not recommended — they can interfere with test results or cause side effects. Always work with a healthcare provider.

Challenges and Limitations of Adrenal Testing in Diabetes

While adrenal testing offers valuable insights, it has limitations:

  • Timing and variability — cortisol has a diurnal rhythm and can spike due to the stress of the blood draw itself (the “white coat” effect). False positives and false negatives are common.
  • Medication interactions — many common drugs (steroids, contraceptives, certain antidepressants, and even some supplements) alter cortisol measurements.
  • Cost and insurance coverage — specialized tests like the ACTH stimulation test may be expensive or require prior authorization.
  • Overdiagnosis of “adrenal fatigue” — this condition is not recognized by mainstream endocrinology, yet many alternative practitioners sell unproven treatments. It is important to use evidence-based testing and avoid pseudoscience.

When used thoughtfully and interpreted by a specialist, adrenal tests can provide actionable data, but they are not a magic bullet.

Integrating Adrenal Testing into Routine Diabetes Care

Incorporating adrenal health into a diabetes management plan requires a team approach. Ideally, a patient with persistent glycemic variability who also has symptoms like fatigue or blood pressure swings should see an endocrinologist who understands both diabetes and adrenal disorders. The process might look like this:

  1. Screening — annual or as-needed assessment of symptoms. Simple questionnaires can flag those who need testing.
  2. Initial testing — morning cortisol, ACTH, and possibly a late-night salivary cortisol or 24-hour urine cortisol.
  3. Confirmatory testing — if initial results are abnormal, proceed with an ACTH stimulation test or dexamethasone suppression test.
  4. Imaging — if Cushing’s is confirmed, MRI or CT to locate the source.
  5. Treatment and re-evaluation — treat the adrenal disorder, then reassess diabetes regimen. Continue to monitor adrenal function periodically, especially after any major illness or surgery.

Patients can also track their own symptoms using a daily log of blood sugar, energy levels, stress, and sleep. This subjective data, combined with objective test results, creates a comprehensive picture.

Future Perspectives

Research continues to explore the link between adrenal function and diabetes. For example, a 2023 study published in The Journal of Clinical Endocrinology & Metabolism found that even in people without overt adrenal disease, subtle cortisol dysregulation was associated with poorer glycemic control in type 2 diabetes. Another area of investigation is the role of aldosterone in insulin resistance — excess aldosterone may worsen diabetes, and drugs like spironolactone (an aldosterone antagonist) show promise in improving glucose metabolism. As these findings evolve, adrenal testing may become a more routine part of diabetes care, not just a last resort.

Conclusion

Adrenal gland testing offers a powerful avenue to refine diabetes treatment plans by uncovering hidden hormonal imbalances that directly affect blood sugar. Whether it is identifying an undiagnosed cortisol deficiency causing dangerous hypoglycemia or confirming cortisol excess driving insulin resistance, these tests provide clarity that cannot be obtained from standard diabetes metrics alone. By working with an endocrinologist, interpreting results correctly, and adjusting treatment accordingly — including medications, lifestyle, and stress reduction — many patients can achieve more stable glucose levels and a better quality of life. As our understanding of the adrenal-diabetes connection deepens, incorporating adrenal health assessments into routine care has the potential to become a standard, evidence-based practice for people with diabetes who struggle with erratic blood sugar.

For further reading, explore resources from the Endocrine Society and the American Diabetes Association. A detailed protocol for adrenal testing in diabetes can be found in this review article on PubMed.